AzTrials
AzTrials

Respiration, ArtificialPhase 3NCT00157287

A Cluster Randomized Trial to Improve Weaning and Extubation From Mechanical Ventilation in Community Hospitals

A Phase 3 study testing Evidence based weaning protocol in people with Respiration, Artificial, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 11 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Protocol directed weaning has been shown to reduce the duration of mechanical ventilation for patients admitted to the intensive care unit (ICU) of tertiary centres. However, this benefit has not previously been studied in a community hospital setting. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Respiration, Artificial
What is being tested?
Evidence based weaning protocol
Type of treatment
Surgery or procedure
How many people
Not given
Where
11 sitesCanada
Study dates
Jun 2003to Apr 2006
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • patients ventilated for more than 24 hours

Who cannot join

  • patients less than 16 years of age patients who receive only non-invasive ventilation patients chronically ventilated at time of ICU admission patients who will not be candidates for weaning from ventilation at time of admission If withdrawl of life support is imminent at the point the patient has been ventilated for 24 hours

Trial locations and contacts

11 sites in 1 country.

11 sites in 1 country

Canada11 sites
  • William Osler Health Centre (Brampton)

    Brampton, Ontario, N6W 2Z8

  • Brant Community Health Systems

    Brantford, Ontario, N3R 1G9

  • Joseph Brant Memorial Hospital

    Burlington, Ontario, L7R 4C4

  • Guelph General Hospital

    Guelph, Ontario, N1E 4J4

  • St. Joseph's Health Care

    London, Ontario, N6A 4V2

  • Trillium Health Centre

    Mississauga, Ontario, L5B 1B8

  • North Bay General Hospital

    North Bay, Ontario, P1B 5A4

  • Lakeridge Health Corporation (Oshawa)

    Oshawa, Ontario, L1G 2B9

  • Stratford General Hospital

    Stratford, Ontario, N5A 2Y6

  • St. Joseph's Health Centre

    Toronto, Ontario, M9R 1B5

  • Hotel Dieu of St. Joseph

    Windsor, Ontario, N9A 1E1

Other trials in Canada

About this study

Protocol directed weaning has been shown to reduce the duration of mechanical ventilation for patients admitted to the intensive care unit (ICU) of tertiary centres. However, this benefit has not previously been studied in a community hospital setting. We therefore sought to evaluate the impact of an evidence-based weaning guideline on the outcomes for patients receiving mechanical ventilation in the ICUs of community hospitals in a cluster randomized controlled trial involving 11 community hospitals.

Being tested
Evidence based weaning protocol
Medical subject headings
Respiratory Aspiration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Evidence based weaning protocolProcedure or surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ICU length of stay

Secondary outcomes (7)
  1. duration of ventilation

  2. length of hospital stay

  3. complications (re-intubation within 48 hours, pneumonia within 48 hours)

  4. ICU mortality

  5. Hospital mortality

  6. ICU readmissions

  7. Qulaity of life

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2005 (estimated)
  2. Study startJun 2003
  3. Primary completionJun 2005
  4. Study completionApr 2006

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
IDs, dates and publications
ClinicalTrials.gov ID
NCT00157287
Sponsor's protocol ID
R-01-076
Status last verified
Aug 2017
First submitted
8 Sep 2005
Last updated
25 Aug 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Evidence based weaning protocol in people with Respiration, Artificial, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 11 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 11 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ICU length of stay. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Aug 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in